SERUM ANTIBODIES IN SIX-YEAR-OLD CHILDREN VACCINATED IN INFANCY WITH A HAEMOPHILUS INFLUENZAE TYPE b-TETANUS TOXOID CONJUGATE VACCINE

This publication has 16 references indexed in Scilit:

• Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age
  The Pediatric Infectious Disease Journal, 1991
• Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate
  The Journal of Pediatrics, 1989
• Prevention ofHaemophilus influenzaeType b Infections in High-Risk Infants Treated with Bacterial Polysaccharide Immune Globulin
  New England Journal of Medicine, 1987
• The Protective Level of Serum Antibodies to the Capsular Polysaccharide of Haemophilus influenzae Type b
  The Journal of Infectious Diseases, 1983
• Intrinsic Tritium Labeling of the Capsular Polysaccharide Antigen of Haemophilus Influenzae Type B
  The Journal of Immunology, 1978
• Antibody to Polyribophosphate of Haemophilus influenzae Type b in Infants and Children: Effect of Immunization with Polyribophosphate
  The Journal of Infectious Diseases, 1977
• Induction of SerumHaemophilus influenzaeType B Capsular Antibodies in Adult Volunteers Fed Cross-ReactingEscherichia coli075:K100:H5
  New England Journal of Medicine, 1975
• Polyribitol-Phosphate: An Antigen of Four Gram-Positive Bacteria Cross-Reactive with the Capsular Polysaccharide of Haemophilus Influenzae Type B
  The Journal of Immunology, 1974
• Quantitative Measurement of “Natural” and Immunization-induced Haemophilus influenzas type b Capsular Polysaccharide Antibodies
  Pediatric Research, 1973